Ragon Institute of MGH, MIT and Harvard Massachusetts General Hospital, Harvard Medical School Building 149, 13th Street, 5th floor, #5217, Charlestown, Boston, MA 02129, USA.
Expert Rev Vaccines. 2010 Dec;9(12):1453-63. doi: 10.1586/erv.10.132.
It is generally believed that the role of CD4(+) T cells is to coordinate the different arms of the adaptive immune system to shape an effective response against a pathogen and regulate nonessential or deleterious activities. However, a growing body of evidence suggests that effector CD4(+) T cells can directly display potent antiviral activity themselves. The presence of cytolytic CD4(+) T cells has been demonstrated in the immune response to numerous viral infections in both humans and in animal models and it is likely that they play a critical role in the control of viral replication in vivo. This article describes the current research on virus-specific cytolytic CD4(+) T cells, with a focus on HIV-1 infection and the implications that this immune response has for vaccine design.
人们普遍认为 CD4(+)T 细胞的作用是协调适应性免疫系统的不同分支,以形成针对病原体的有效反应,并调节非必需或有害的活性。然而,越来越多的证据表明,效应 CD4(+)T 细胞本身可以直接表现出强大的抗病毒活性。在人类和动物模型中对多种病毒感染的免疫反应中已经证明存在细胞毒性 CD4(+)T 细胞,并且它们很可能在体内控制病毒复制中发挥关键作用。本文描述了针对病毒特异性细胞毒性 CD4(+)T 细胞的当前研究,重点是 HIV-1 感染以及这种免疫反应对疫苗设计的意义。